View Filing Data

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2020	May 01, 2020
Cover [Abstract]
Entity registrant name	TheRealReal, Inc.
Trading symbol	REAL
Entity central index key	0001573221
Current fiscal year end date	--12-31
Entity filer category	Non-accelerated Filer
Document type	10-Q
Document period end date	Mar. 31, 2020
Document fiscal year focus	2020
Document fiscal period focus	Q1
Amendment flag	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Small Business	false
Entity Interactive Data Current	Yes
Entity common stock, shares outstanding		86,894,511
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-38953
Entity Tax Identification Number	45-1234222
Entity Address, Address Line One	55 Francisco Street
Entity Address, Address Line Two	Suite 600
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94133
City Area Code	855
Local Phone Number	435-5893
Title of 12(b) Security	Common stock, $0.00001 par value
Security Exchange Name	NASDAQ
Document Quarterly Report	true
Document Transition Report	false
Entity Incorporation, State or Country Code	DE

Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 134,662	$ 154,446
Short-term investments	168,592	208,811
Accounts receivable	3,089	7,779
Inventory, net	24,916	23,599
Prepaid expenses and other current assets	11,273	13,804
Total current assets	342,532	408,439
Property and equipment, net	59,637	55,831
Operating lease right-of-use assets	124,346
Other assets	3,025	2,660
Total assets	529,540	466,930
Current liabilities
Accounts payable	9,916	11,159
Accrued consignor payable	33,489	52,820
Operating lease liabilities, current portion	14,209
Other accrued and current liabilities	43,941	54,567
Total current liabilities	101,555	118,546
Operating lease liabilities, net of current portion	120,174
Other noncurrent liabilities	1,038	9,456
Total liabilities	222,767	128,002
Commitments and contingencies (Note 10)
Stockholders’ equity:
Common stock, $0.00001 par value; 500,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 86,850,694 and 85,872,320 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively	1	1
Additional paid-in capital	699,249	693,426
Accumulated other comprehensive income	321	7
Accumulated deficit	(392,798)	(354,506)
Total stockholders’ equity	306,773	338,928
Total liabilities and stockholders’ equity	$ 529,540	$ 466,930

Condensed Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	86,850,694	85,872,320
Common stock, shares, outstanding	86,850,694	85,872,320

Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue:
Total revenue	$ 78,239	$ 70,582
Cost of revenue:
Total cost of revenue	29,042	28,200
Gross profit	49,197	42,382
Operating expenses:
Marketing	12,922	11,733
Operations and technology	40,737	31,544
Selling, general and administrative	35,104	22,319
Total operating expenses	88,763	65,596
Loss from operations	(39,566)	(23,214)
Interest income	1,286	405
Interest expense	(20)	(131)
Other income (expense), net	8	(282)
Loss before provision for income taxes	(38,292)	(23,222)
Net loss	(38,292)	(23,222)
Accretion of redeemable convertible preferred stock to redemption value		(3,355)
Net loss attributable to common stockholders	$ (38,292)	$ (26,577)
Net loss per share attributable to common stockholders, basic and diluted	$ (0.44)	$ (3.05)
Shares used to compute net loss per share attributable to common stockholders, basic and diluted	86,588,796	8,705,664
Consignment and Service Revenue
Revenue:
Total revenue	$ 65,297	$ 55,575
Cost of revenue:
Total cost of revenue	18,088	15,946
Direct Revenue
Revenue:
Total revenue	12,942	15,007
Cost of revenue:
Total cost of revenue	$ 10,954	$ 12,254

Condensed Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]
Net loss	$ (38,292)	$ (23,222)
Other comprehensive income (loss), net of tax:
Unrealized gain on investments	314	28
Comprehensive loss	$ (37,978)	$ (23,194)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Condensed Statements of Redeemable Convertible Preferred Stock, Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Redeemable Convertible Preferred Stock	Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2018	$ (257,690)					$ (25)	$ (257,665)
Beginning balance, shares at Dec. 31, 2018		31,053,601	73,724,645
Beginning balance at Dec. 31, 2018		$ 151,381	$ 142,819
Beginning balance, shares at Dec. 31, 2018				8,593,077
Issuance of convertible preferred stock, net of issuance costs		$ 43,572
Issuance of convertible preferred stock, net of issuance costs, shares		6,350,345
Issuance of convertible preferred stock upon conversion of notes, net of issuance costs			$ 26,279
Issuance of convertible preferred stock upon conversion of notes, net of issuance costs, shares			3,831,766
Accretion of redeemable convertible preferred stock to redemption value	(3,355)	$ 3,355			$ (3,260)		(95)
Compensation expense related to stock sales by current and former employees	819				819
Issuance of common stock upon exercise of options	1,319				1,319
Issuance of common stock upon exercise of options, shares				739,053
Issuance of common stock upon exercise of warrants	13				13
Issuance of common stock upon exercise of warrants, shares				4,935
Stock-based compensation expense	1,109				1,109
Other comprehensive income	28					28
Net loss	(23,222)						(23,222)
Ending balance at Mar. 31, 2019	$ (280,979)					3	(280,982)
Beginning balance, shares at Mar. 31, 2019	114,960,357	37,403,946	77,556,411
Beginning balance at Mar. 31, 2019	$ 367,406	$ 198,308	$ 169,098
Beginning balance, shares at Mar. 31, 2019				9,337,065
Beginning balance at Dec. 31, 2019	338,928			$ 1	693,426	7	(354,506)
Beginning balance, shares at Dec. 31, 2019				85,872,320
Issuance of common stock upon exercise of options	2,564				2,564
Issuance of common stock upon exercise of options, shares				964,085
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for employee taxes	(151)				(151)
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for employee taxes, shares				14,289
Stock-based compensation expense	3,410				3,410
Other comprehensive income	314					314
Net loss	(38,292)						(38,292)
Ending balance at Mar. 31, 2020	$ 306,773			$ 1	$ 699,249	$ 321	$ (392,798)
Beginning balance, shares at Mar. 31, 2020				86,850,694

Condensed Statements of Redeemable Convertible Preferred Stock, Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) (Parenthetical) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($)
Series H Redeemable Convertible Preferred Stock
Stock issuance costs	$ 86
Series H Convertible Preferred Stock
Stock issuance costs	$ 63

Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (38,292)	$ (23,222)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	4,145	2,808
Stock-based compensation expense	3,410	1,109
Reduction of operating lease right-of-use assets	4,121
Bad debt expense	455	321
Compensation expense related to stock sales by current and former employees		819
Change in fair value of convertible preferred stock warrant liability		280
Accretion of unconditional endowment grant liability	23	26
Accretion of debt discounts		7
Amortization of premiums (discounts) on short-term investments	207	(40)
Changes in operating assets and liabilities:
Accounts receivable	4,235	(4,050)
Inventory, net	(1,317)	(173)
Prepaid expenses and other current assets	2,356	(2,388)
Other assets	(365)	(111)
Operating lease liability	(2,721)
Accounts payable	(2,206)	797
Accrued consignor payable	(19,331)	1,292
Other accrued and current liabilities	(8,865)	(475)
Other noncurrent liabilities	(412)	349
Net cash used in operating activities	(54,971)	(22,571)
Cash flow from investing activities:
Purchases of short-term investments	(73,280)
Proceeds from maturities of short-term investments	114,020	12,873
Capitalized proprietary software development costs	(1,480)	(1,686)
Purchases of property and equipment	(6,486)	(3,743)
Net cash provided by investing activities	32,774	7,444
Cash flow from financing activities:
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs		43,572
Proceeds from issuance of convertible preferred stock, net of issuance costs		26,279
Proceeds from exercise of stock options and common stock warrants	2,564	1,332
Payment of deferred offering costs		(222)
Taxes paid related to restricted stock vesting	(151)
Repayment of debt		(1,250)
Net cash provided by financing activities	2,413	69,711
Net (decrease) increase in cash, cash equivalents and restricted cash	(19,784)	54,584
Cash, cash equivalents, and restricted cash
Beginning of period	154,446	45,627
End of period	134,662	100,211
Supplemental disclosures of cash flow information
Cash paid for interest	4	98
Supplemental disclosures of non-cash investing and financing activities
Accretion of redeemable convertible preferred stock to redemption value		3,355
Purchases of property and equipment included in accounts payable and other current liabilities	(771)	(704)
Purchases of capitalized proprietary software development costs included in accounts payable and other current liabilities	$ 756
Deferred offering costs in accounts payable and accrued liabilities		$ 1,457

Description of Business and Basis of Presentation

3 Months Ended

Mar. 31, 2020

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Description of Business and Basis of Presentation

Note 1. Description of Business and Basis of Presentation

Organization and Description of Business

The RealReal, Inc. (the “Company”) is an online marketplace for authenticated, consigned luxury goods across multiple categories, including women’s, men’s, kids’, jewelry and watches, and home and art. The Company was incorporated in the state of Delaware on March 29, 2011 and is headquartered in San Francisco, California.

Impact of the Coronavirus (“COVID-19”) Pandemic

The COVID-19 pandemic has negatively impacted the global economy, disrupted consumer spending and global supply chains, and created significant volatility of financial markets. While the ultimate health and economic impact of the COVID-19 pandemic is highly uncertain, the Company expects its business operations and results of operations, including its net revenues, earnings and cash flows, will be materially adversely impacted, including as a result of reduced operations in its fulfillment centers, temporary closures of retail stores, decreased productivity due to shelter-in-place orders, and a slowdown in the U.S. economy and uncertain global economic outlook.

The Company believes that its financial resources, along with managing discretionary expenses, will allow it to manage the anticipated impact of COVID-19 on the Company’s business operations for the foreseeable future. The Company believes its existing cash and cash equivalents and short-term investments as of March 31, 2020 will be sufficient to meet its working capital and capital expenditures needs for at least the next 12 months.

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the requirements of the U.S. Securities and Exchange Commission (the “SEC”) for interim reporting. The Company’s functional and reporting currency is the U.S. dollar.

The condensed balance sheet as of December 31, 2019 included herein was derived from the audited financial statements as of that date. The accompanying unaudited condensed financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly the Company’s financial position, results of operations, comprehensive loss, redeemable convertible preferred stock, convertible preferred stock, and stockholders’ equity (deficit), and cash flows for the periods presented.

These unaudited condensed financial statements should be read in conjunction with the Company’s financial statements and notes included in our Annual Report on Form 10-K filed with the SEC on March 11, 2020.

Initial Public Offering

The Company’s registration statement on Form S-1 (the “IPO Registration Statement”) related to its initial public offering (“IPO”) was declared effective on June 27, 2019, and the Company’s common stock began trading on the Nasdaq Global Select Market on June 28, 2019. On July 2, 2019, the Company completed its IPO, selling 15,000,000 shares of common stock at a price to the public of $20.00 per share, plus an additional 2,250,000 shares of common stock at a price to the public of $20.00 per share pursuant to the exercise of the underwriters’ option to purchase additional shares. The Company received aggregate net proceeds of $315.5 million after deducting underwriting discounts and commissions of $24.1 million and issuance costs of $5.3 million.

Immediately prior to the completion of the IPO, the Company filed its Amended and Restated Certificate of Incorporation, which authorizes a total of 500,000,000 shares of common stock, and 50,000,000 shares of undesignated preferred stock.

The Company recorded the conversion of 114,960,357 shares of convertible preferred stock and redeemable convertible preferred stock then outstanding into 58,363,606 shares of common stock to additional paid-in capital. All outstanding preferred stock warrants converted into an aggregate of 103,563 common stock warrants.

Reverse Stock Split

On June 13, 2019 the Company effected a reverse split of shares of the Company’s common stock on a 1-for-2 basis (the “Reverse Stock Split”). All issued and outstanding shares of common stock, warrants for common stock, options to purchase common stock and the related per share amounts contained in the financial statements have been retroactively adjusted to reflect this Reverse Stock Split for all periods presented. The par value and authorized shares of common stock were not adjusted as a result of the Reverse Stock Split. Additionally, the authorized, issued and outstanding shares of redeemable convertible preferred stock and convertible preferred stock and their related per share amounts, other than the conversion price per share, were not adjusted as a result of the Reverse Stock Split.

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant items subject to such estimates and assumptions include those related to revenue recognition, including the returns reserve and material right related to the Company’s tiered consignor commission plan, valuation of inventory, stock-based compensation, redemption value of redeemable convertible preferred stock, incremental borrowing rates related to lease liability, and other contingencies. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.

The Company is not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require it to update its estimates, assumptions or revise the carrying value of its assets or liabilities. Its estimates may change, however, as new events occur and additional information is obtained; any such changes will be recognized in the financial statements. Actual results could differ from estimates, and any such differences may be material to the financial statements.

Net Loss per Share Attributable to Common Stockholders

The Company follows the two-class method when computing net loss per common share when shares are issued that meet the definition of participating securities. The two-class method determines net loss per common share for each class of common stock and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income (loss) available or attributable to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. Before the IPO, the Company’s redeemable convertible preferred stock and convertible preferred stock were considered participating securities. However, the holders of such shares did not have a contractual obligation to participate in the Company’s losses.

For periods in which the Company reports net losses, diluted net loss per common share attributable to common stockholders is the same as basic net loss per common share attributable to common stockholders, because potentially dilutive common shares are not assumed to have been issued within the calculation, if their effect is anti-dilutive.

Revenue Recognition

The Company generates revenue from the sale of pre-owned luxury goods through its online marketplace and retail locations.

Consignment and Service Revenue

The Company provides a service to sell pre-owned luxury goods on behalf of consignors to buyers through its online marketplace and retail locations. The Company retains a percentage of the proceeds received as payment for its consignment service, which the Company refers to as its take rate. The Company reports consignment revenue on a net basis as an agent and not the gross amount collected from the buyer. Title to the consigned goods remain with the consignor until transferred to the buyer subsequent to purchase of the consigned goods and expiration of the allotted return period. The Company does not take title of consigned goods at any time except in certain cases where returned goods become Company-owned inventory.

The Company recognizes consignment revenue upon purchase of the consigned good by the buyer as its performance obligation of providing consignment services to the consignor is satisfied at that point. Consignment revenue is recognized net of certain buyer incentives and estimated returns and cancellations. The Company recognizes a returns reserve based on historical experience, which is recorded in other accrued and current liabilities on the balance sheets (see Note 5). Sales tax assessed by governmental authorities is excluded from revenue.

Certain transactions provide consignors with a material right resulting from the tiered consignor commission plan. Under this plan, the amount an individual consignor receives for future sales of consigned goods may be dependent on previous consignment sales for that consignor within his/her consignment period. Accordingly, in certain consignment transactions, a small portion of the Company’s consignment revenue is allocated to such material right using the portfolio method and recorded as deferred revenue, which is recorded in other accrued and current liabilities on the balance sheets.

The Company charges shipping fees to buyers and has elected to treat shipping and handling activities performed after control transfers to the buyer as fulfillment activities. All outbound shipping and handling costs are accounted for as fulfillment costs in cost of consignment and service revenue at the time revenue is recognized.

The Company also generates subscription revenue from monthly memberships allowing buyers early access to shop for luxury goods. The buyers receive the early access and other benefits over the term of the subscription period, which represents a single stand-ready performance obligation. Therefore, the subscription fees paid by the buyer are recognized over the monthly subscription period. Subscription revenue was not material in the three months ended March 31, 2020 and 2019.

Direct Revenue

The Company generates direct revenue from the sale of Company-owned inventory. The Company recognizes direct revenue on a gross basis upon shipment of the purchased good to the buyer as the Company acts as the principal in the transaction. Direct revenue is recognized net of incentives and estimated returns. Sales tax assessed by governmental authorities is excluded from revenue. Cost of direct revenue is also recognized upon shipment to the buyer in an amount equal to that paid to the consignor from the original consignment sale.

Incentives

Promotional incentives, which include basket promotional code discounts and other credits, may periodically be offered to consignors and buyers. These are treated as a reduction of consignment and service revenue and direct revenue. Additionally, the Company may offer site credits to buyers on current transactions to be applied towards future transactions, which are accounted as deferred revenue and included in other accrued and current liabilities on the balance sheets.

Contract Liabilities

The Company’s contractual liabilities consist of deferred revenue for material rights primarily related to the tiered consignor commission plan totaling $2.6 million as of March 31, 2020 and $3.5 million as of December 31, 2019, which are recognized as revenue using a portfolio approach based on the pattern of exercise, and certain unredeemed site credits, which were immaterial as of March 31, 2020 and December 31, 2019. Contract liabilities are recorded in other accrued and current liabilities on the balance sheets and are generally expected to be recognized within one year.

Cost of Revenue

Cost of consignment and service revenue consist of shipping costs, credit card fees, packaging, customer service personnel-related costs, and website hosting services. Cost of direct revenue consists of the cost of goods sold, credit card fees, packaging, customer service personnel-related costs, and website hosting services.

Stock-based Compensation

Stock-based compensation expense related to employees is measured based on the grant-date fair value of the awards. Compensation expense is recognized in the statements of operations over the period during which the employee is required to perform services in exchange for the award (the vesting period of the applicable award) using the straight-line method. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model and accounts for forfeitures as they occur. The fair value of restricted stock units (“RSUs”) is estimated based on the fair market value of the Company’s common stock on the date of grant, which is determined based on the closing price of the Company’s common stock.

Certain employees have sold their shares of the Company’s common stock to the Company’s existing investors. In such secondary sale transactions, the Company recorded the difference in purchase price and the fair value of such shares as compensation expense within selling, general and administrative in the statements of operations and a corresponding credit to additional paid-in capital.

Cash, Cash Equivalents and Restricted Cash

The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in U.S. treasury securities. Restricted cash consists of cash deposited with a financial institution as collateral for the Company’s letters of credit for its facility leases and the Company’s credit cards.

The following table provides a reconciliation of cash, cash equivalents and restricted cash that sum to the total of the same amounts shown in the statements of cash flows (in thousands):

	March 31, 2020		March 31, 2019
Cash and cash equivalents	$	134,662	$	88,790
Restricted cash		—		11,421
Total cash, cash equivalents and restricted cash	$	134,662	$	100,211

Short-term Investments

The Company has classified and accounted for its short-term investments as available-for-sale which are carried at fair value on its balance sheets. Available-for-sale securities with remaining maturities of 12 months or less are classified as short term and available-for-sale securities with remaining maturities greater than 12 months are classified as long term. The Company records any unrealized gains and losses within accumulated other comprehensive income (loss) as a component of stockholders’ equity (deficit), except for unrealized losses determined to be other than temporary, of which there were none as of March 31, 2020 and 2019.

The Company evaluates its short-term investments periodically for possible impairment. A decline in the fair value below the amortized costs of the short-term investment is considered an other-than-temporary impairment if the Company has the intent to sell the short-term investments or it is more likely than not that the Company will be required to sell the short-term investment before recovery of the entire amortized cost basis.

Inventory, Net

Inventory primarily consists of finished goods arising from goods returned after the title has transferred from the buyer to the Company in an amount equal to that paid to the consignor. The Company also periodically purchases finished goods directly from vendors. Inventory is valued at the lower of cost and net realizable value using the specific identification method and the Company records provisions, as appropriate, to write down obsolete and excess inventory to estimated net realizable value. After the inventory value is reduced, adjustments are not made to increase it from the estimated net realizable value.

Our provisions to write down obsolete and excess inventory to net realizable value have not been material for the three months ended March 31, 2020 and 2019.

Software Development Costs

Proprietary software includes the costs of developing the Company’s internal proprietary business platform and automation projects. The Company capitalizes qualifying proprietary software development costs that are incurred during the application development stage. Capitalization of costs begins when two criteria are met: (1) the preliminary project stage is completed and (2) it is probable that the software will be completed and used for its intended function. Such costs are capitalized in the period incurred. Capitalization ceases and amortization begins when the software is substantially complete and ready for its intended use, including the completion of all significant testing. Costs related to preliminary project activities and post-implementation operating activities are expensed as incurred.

Accretion of Redeemable Convertible Preferred Stock

The carrying value of the redeemable convertible preferred stock that is probable of redemption is accreted to redemption value from the date of issuance to the earliest redemption date using the effective interest method until redemption is no longer probable. Increases to the carrying value of redeemable convertible preferred stock recognized in each period are charged to additional paid-in capital, or in the absence of additional paid-in capital, charged to accumulated deficit.

Convertible Preferred Stock Warrant Liability

The Company issued convertible preferred stock warrants in conjunction with the issuance of debt. Such warrants were recorded as other noncurrent liabilities on the balance sheets at their estimated fair value because the shares underlying the warrants may obligate the Company to transfer assets to the holders at a future date under certain circumstances such as a deemed liquidation event. The warrants are subject to re-measurement at each balance sheet date and the change in fair value, if any, is included in other income (expense), net. The Company continued to remeasure these warrants until the earlier of the expiration, exercise or conversion of the convertible preferred stock warrants into common warrants, which occurred upon the completion of the IPO on July 2, 2019. In connection with the completion of the IPO, the convertible preferred stock warrants automatically converted into common stock warrants. Upon conversion of the convertible preferred stock warrants, the related convertible preferred stock warrant liability was reclassified to additional paid-in capital.

Leases

Prior to the adoption of ASC 842

Leases are reviewed for classification as operating or capital leases. For operating leases, the Company recognizes rent on a straight-line basis over the term of the lease. The Company records the difference between cash payments and rent expense recognized as a deferred rent liability included in other accrued and current liabilities and other noncurrent liabilities on the balance sheets. Incentives granted under the Company’s facility leases, including allowances to fund leasehold improvements, are deferred and are recognized as adjustments to rental expense on a straight-line basis over the term of the lease.

Subsequent to the adoption of ASC 842

Contracts that have been determined to convey the right to use an identified asset are evaluated for classification as an operating or finance lease. For the Company’s operating leases, the Company records a lease liability based on the present value of the lease payments at lease inception, using the applicable incremental borrowing rate. The Company estimates the incremental borrowing rate based on its own synthetic credit ratings, corresponding yield curves, and the terms of each lease, from the financial credit market information available at the lease commencement date. The corresponding right-of-use asset is recorded based on the corresponding lease liability at lease inception, adjusted for payments made to the lessor at or before the commencement date, initial direct costs incurred and any tenant incentives allowed for under the lease. The Company does not include optional renewal terms or early termination provisions unless the Company is reasonably certain such options would be exercised at the inception of the lease. Operating lease right-of-use assets, operating lease liabilities, current portion and operating lease liabilities, net of current portion are included on the Company’s condensed balance sheet.

The Company has elected the practical expedients that allows for the combination of lease components and non-lease components and to record short-term leases as lease expense on a straight-line basis on the condensed statements of operations. Variable lease payments are recorded as expense as they are incurred.

The Company has finance leases for several vehicles, and the amounts of finance lease right-of-use assets and finance lease liabilities have been immaterial to date.

Concentrations of Credit Risks

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, accounts receivable, and investments. At times, such amount may exceed federally-insured limits. The Company reduces credit risk by placing its cash and cash equivalents, restricted cash and investments with major financial institutions within the United States.

As of March 31, 2020 and December 31, 2019, there were no customers that represented 10% or more of the Company’s accounts receivable balance and there were no customers that individually exceeded 10% of the Company’s total revenue for each of the three months ended March 31, 2020 and 2019.

Recently Adopted Accounting Pronouncements

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 is aimed at making leasing activities more transparent and comparable. This new standard requires substantially all leases to be recognized by lessees on their balance sheets as a right-of-use asset and corresponding lease liability, including leases currently accounted for as operating leases. The new standard is effective for non-public entities in fiscal years beginning after December 15, 2021 and interim periods in fiscal years beginning after December 15, 2022. Early adoption is permitted for all entities. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. As an “emerging growth company” as defined in the JOBS Act, the new standard is effective for the Company beginning January 1, 2022. The Company chose to early adopt the standard on January 1, 2020. The Company can choose to adopt new or revised accounting standards earlier than such time those standards apply to private companies and retain its election for the extended transition period, if early adoption is permitted for all entities.

The Company adopted and began applying the standard on January 1, 2020 using the modified retrospective approach and applied it to all existing leases as of the adoption date, which allows for a cumulative-effect adjustment to retained earnings on the adoption date. The Company will continue to present prior periods amounts under ASC 840. In addition, the Company elected the package of practical expedients permitted under the transition guidance within the new standard which does not require the Company to reassess whether contracts that expired prior to the adoption date contained an embedded lease, reassess historical lease classification, or evaluate direct costs for leases that were in effect at the adoption date.

As a result of implementing this guidance, the Company recognized $110.3 million in right of use assets as of January 1, 2020. The Company also recorded $12.8 million in current operating lease liabilities and $106.2 million in operating lease liabilities, net of current portion in its condensed balance sheet as of January 1, 2020.

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820). This standard modifies disclosure requirements related to fair value measurement and is effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance effective January 1, 2020, which did not have a material impact on its financial statements.

Recently Issued Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326). The standard amends guidance on reporting credit losses for assets held at amortized cost basis and available for sale debt securities. For available for sale debt securities, credit losses will be presented as an allowance rather than as a write-down. As an “emerging growth company” as defined in the JOBS Act, the new standard is effective for the Company for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted for all entities. The Company does not expect the adoption of this standard to have a material impact on the operating results.

In June 2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic 718), which expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. As an “emerging growth company” as defined in the JOBS Act, the standard is effective for fiscal years beginning after December 15, 2019, and interim periods in fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than the Company’s adoption date of ASC 606. The Company does not expect the adoption of this standard to have a material impact on the operating results.

Cash, Cash Equivalents and Short-term Investments

3 Months Ended

Mar. 31, 2020

Cash And Cash Equivalents [Abstract]

Cash, Cash Equivalents, and Short-term Investments

Note 3. Cash, Cash Equivalents and Short-term Investments

The following tables summarize the estimated value of the Company’s cash, cash equivalents and short-term investments (in thousands):

	March 31, 2020
	Amortized Cost		Unrealized Gain		Unrealized Loss			Fair Value
Cash and cash equivalents:
Cash	$	50,257	$	—	$	—		$	50,257
U.S. Treasury securities		39,978		20		—			39,998
Money market fund		39,412		—		—			39,412
Corporate bonds		—		—		—			—
Agency bonds		—		—		—			—
Commercial paper		4,994		1		—			4,995
Total cash and cash equivalents	$	134,641	$	21	$	—		$	134,662
Short-term investments:
U.S. Treasury securities	$	100,928	$	511	$	—		$	101,439
Corporate bonds		51,569		—		(225	)		51,344
Agency bonds		10,000		13		—			10,013
Commercial paper		5,794		2		—			5,796
Total short-term investments	$	168,291	$	526	$	(225	)	$	168,592

	December 31, 2019
	Amortized Cost		Unrealized Gain		Unrealized Loss			Fair Value
Cash and cash equivalents:
Cash	$	111,319	$	—	$	—		$	111,319
U.S. Treasury securities		29,981		—		—			29,981
Money market fund		5,399		—		—			5,399
Corporate bonds		3,749		—		—			3,749
Agency bonds		2,000		—		—			2,000
Commercial paper		1,998		—		—			1,998
Total cash and cash equivalents	$	154,446	$	—	$	—		$	154,446
Short-term investments:
U.S. Treasury securities	$	151,857	$	13	$	—		$	151,870
Corporate bonds		38,149		—		(5	)		38,144
Agency bonds		11,028		—		(2	)		11,026
Commercial paper		7,770		1		—			7,771
Total short-term investments	$	208,804	$	14	$	(7	)	$	208,811

As of March 31, 2020 and December 31, 2019, the contractual maturity for the short-term investments is less than one year. For the three months ended March 31, 2020 and 2019, the Company recognized no material realized gains or losses on short-term investments.

Fair Value Measurement

3 Months Ended

Mar. 31, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurement

Note 4. Fair Value Measurement

Assets and liabilities recorded at fair value on a recurring basis on the balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:

Level 1—Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.

Level 2—Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

There were no transfers between Level 1, Level 2 or Level 3 of the fair value hierarchy during the periods presented.

The following tables provide the financial instruments measured at fair value (in thousands):

	March 31, 2020
	Level 1		Level 2		Level 3		Total
Assets
Cash equivalents:
U.S. Treasury securities	$	39,998	$	—	$	—	$	39,998
Money market fund		39,412		—		—		39,412
Commercial paper		—		4,995		—		4,995
Total cash equivalents	$	79,410	$	4,995	$	—	$	84,405
Short-term investments:
U.S. Treasury securities	$	101,439	$	—	$	—	$	101,439
Corporate bonds		—		51,344		—		51,344
Agency bonds		—		10,013		—		10,013
Commercial paper		—		5,796		—		5,796
Total short-term investments	$	101,439	$	67,153	$	—	$	168,592

	December 31, 2019
	Level 1		Level 2		Level 3		Total
Assets
Cash equivalents:
U.S. Treasury securities	$	29,981	$	—	$	—	$	29,981
Money market fund		5,399		—		—		5,399
Corporate bonds		—		3,749		—		3,749
Agency bonds		—		2,000		—		2,000
Commercial paper		—		1,998		—		1,998
Total cash equivalents	$	35,380	$	7,747	$	—	$	43,127
Short-term investments:
U.S. Treasury securities	$	151,870	$	—	$	—	$	151,870
Corporate bonds		—		38,144		—		38,144
Agency bonds		—		11,026		—		11,026
Commercial paper		—		7,771		—		7,771
Total short-term investments	$	151,870	$	56,941	$	—	$	208,811

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Balance Sheet Components

3 Months Ended

Mar. 31, 2020

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components

Note 5. Balance Sheet Components

Property and Equipment, Net

Property and equipment, net is recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are recorded on a straight-line basis over the estimated useful lives of the respective assets. Property and equipment, net consists of the following (in thousands):

	March 31, 2020			December 31, 2019
Proprietary software	$	25,554		$	23,318
Furniture and equipment		22,848			21,083
Automobiles		491			718
Leasehold improvements		47,207			43,505
		96,100			88,624
Less: accumulated depreciation and amortization		(36,463	)		(32,793	)
Property and equipment, net	$	59,637		$	55,831

Depreciation and amortization expense on property and equipment was $4.1 million and $2.8 million for the three months ended March 31, 2020 and 2019, respectively.

Other Accrued and Current Liabilities

Other accrued and current liabilities consist of the following (in thousands):

	March 31, 2020		December 31, 2019
Returns reserve	$	10,662	$	17,005
Accrued compensation		8,745		11,626
Site credit liability		5,784		5,080
Accrued sales tax and other taxes		3,984		6,132
Deferred revenue		3,690		4,767
Accrued marketing and outside services		8,728		6,830
Other		2,348		3,127
Other accrued and current liabilities	$	43,941	$	54,567

Debt and Convertible Preferred Stock Warrants

3 Months Ended

Mar. 31, 2020

Debt Disclosure [Abstract]

Debt and Convertible Preferred Stock Warrants

Note 6. Debt and Convertible Preferred Stock Warrants

Term Loans

In 2013, the Company entered into an agreement to obtain a term loan facility (“Term Loan Facility”) in the amount of $5.0 million for general corporate purposes and working capital expenditures. In 2014, 2015 and 2016, the Company amended its Term Loan Facility to increase the amount borrowed under the facility by $11.6 million. The Term Loan Facility is secured by liens on substantially all of the Company’s present and future assets.

The Term Loan Facility includes affirmative, negative and financial covenants that restrict the Company’s ability to, among other things, incur additional indebtedness, make investments, sell or otherwise dispose of assets, pay dividends or repurchase stock. The Term Loan Facility’s financial covenants required the Company to achieve at least 80% of its forecasted gross revenue and a liquidity ratio on a monthly basis.

In 2017, the Company executed the eighth amendment (“Eight Amendment”) to the Term Loan Facility. The Eighth Amendment refinanced the $15.0 million repayment schedule to be two term loans, which included a $7.5 million interest only term loan with a maturity date of January 31, 2019 (“Term Loan I”), and the remaining $7.5 million under the existing Term Loan Facility with a maturity date of January 1, 2020 (“Term Loan II”) (together the “Term Loans”).

In 2018, the Company entered into the ninth, tenth, eleventh, and twelfth amendment (“Ninth Amendment,” “Tenth Amendment,” “Eleventh Amendment” and “Twelfth Amendment”) to the existing Term Loans. The Ninth Amendment removed the liquidity ratio covenant, amended Term Loan I to be due in 30 equal monthly installments, plus all accrued interest, beginning July 31, 2018, increased the variable annual interest rate from 0.10% above the prime rate to 0.35% above the prime rate and extended the maturity date of Term Loan I to January 31, 2021.

The Eighth Amendment and Ninth Amendment required the Company to pay a combined success fee of $0.3 million upon (1) any sale or licensing of all or substantially all of the Company’s assets, (2) any change in control of the Company, or (3) an initial public offering of the Company’s equity securities. The Ninth Amendment also required the Company to pay an additional success fee of $0.1 million upon the sale or issuance of the Company’s equity securities or subordinated debt securities for net cash proceeds of at least $50.0 million on or prior to June 30, 2018. The Company paid the $0.1 million success fee upon the Series G convertible preferred stock financing in June 2018 and the $0.3 million success fee related to its IPO in July 2019.

The Tenth and Twelfth Amendments adjusted and waived certain covenant violations which were subsequently amended and met. The Eleventh Amendment provided an additional letter of credit of $1.5 million for corporate credit cards with a maturity date of August 1, 2019.

On July 26, 2019 the Company fully repaid the principal of its Terms Loans in the amount of $6.5 million. With the repayment of the term loans, the Company was no longer subject to debt covenants as of March 31, 2020. During the three months ended March 31, 2020 and 2019, the Company recorded interest expense related to the Term Loans of zero and $0.1 million, respectively.

Warrants Issued with Term Loan Facility

During the period from 2013 to 2016, in connection with the Term Loan Facility, the Company issued convertible preferred stock warrants, which included warrants to purchase 131,652 shares of its Series B convertible preferred stock with an exercise price of $1.03 per share, 6,868 shares of its Series C convertible preferred stock with an exercise price of $2.18 per share, 43,010 shares of its Series D convertible preferred stock with an exercise price of $2.79 per share and 25,597 shares of its Series E convertible preferred stock with an exercise price of $2.93 per share (together the “Convertible Preferred Stock Warrants”). The Convertible Preferred Stock Warrants were exercisable from the date of issuance and have a 10-year term. The initial estimated fair value of the Convertible Preferred Stock Warrants was recorded as convertible preferred stock warrant liability with an offset to the debt discount associated with the Term Loan Facility. The debt discount is amortized to interest expense over the repayment period of the loan using the effective-interest method. All convertible Preferred Stock Warrants were converted to common stock warrants and exercised through net share settlement in July 2019. No warrants were outstanding as of March 31, 2020.

Convertible Preferred Stock and Redeemable Convertible Preferred Stock

3 Months Ended

Mar. 31, 2020

Temporary Equity Disclosure [Abstract]

Convertible Preferred Stock and Redeemable Convertible Preferred Stock

Note 7. Convertible Preferred Stock and Redeemable Convertible Preferred Stock

In March 2019, the Company sold 6,350,345 shares of Series H redeemable convertible preferred stock and 3,831,766 shares of Series H convertible preferred stock at $6.8748 per share to new and existing investors for aggregate gross proceeds of $70.0 million. At March 31, 2019, convertible preferred stock and redeemable convertible preferred stock consisted of the following (in thousands, except share amounts):

	March 31, 2019
	Shares Authorized		Shares Issued and Outstanding		Net Carrying Value		Aggregate Liquidation Preference
Series A		18,960,000		18,941,619	$	9,161	$	9,217
Series B		13,784,443		13,652,791		13,774		14,000
Series C		9,335,659		9,328,791		20,289		20,374
Series D		14,367,652		14,324,642		39,886		40,000
Series E		13,612,543		13,586,946		39,880		40,000
Series F		12,956,724		12,956,724		56,154		58,397
Series G		21,986,733		21,986,733		118,325		123,881
Series H		10,182,113		10,182,111		69,937		70,138
Total		115,185,867		114,960,357	$	367,406	$	376,007

On July 2, 2019 and immediately prior to the completion of the IPO, all outstanding shares of convertible preferred stock and redeemable convertible preferred stock then outstanding converted into 58,363,606 shares of common stock. The carrying value of the redeemable convertible preferred stock was accreted to redemption value from the date of issuance to the earliest redemption date using the effective interest method. As of March 31, 2019, the Company determined that redemption of the redeemable convertible preferred stock was not probable and as such, did not record any additional accretion after March 31, 2019.

Share-based Compensation Plans

3 Months Ended

Mar. 31, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Share-based Compensation Plans

Note 8. Share-based Compensation Plans

2011 Equity Incentive Plan

In 2011, the Company adopted the Equity Incentive Plan (2011 Plan) authorizing the granting of incentive stock options (ISOs) and non-statutory stock options (NSOs) to eligible participants for up to 12,987,255 shares of common stock. Under the 2011 Plan, incentive stock options and non-statutory stock options are to be granted at an exercise price that is no less than 100% of the fair value of the stock at the date of grant. Options generally vest over four years and are exercisable for up to 10 years after the date of grant. Incentive stock options granted to stockholders who own more than 10% of the outstanding stock of the Company at the time of grant must be issued at an exercise price no less than 110% of the fair value of the stock on the date of grant. The 2011 Plan has been replaced by the Company’s 2019 Plan as defined below with respect to future equity awards.

2019 Equity Incentive Plan

In connection with the Company’s initial public offering, the Company adopted the 2019 Equity Incentive Plan (the “2019 Plan”). The 2019 Plan allows the Company to grant stock options, stock appreciation rights, restricted stock, restricted stock units and performance awards to participants. Subject to the terms and conditions of the 2019 Plan, the initial number of shares authorized for grants under the 2019 Plan is 8,000,000.

Employee Stock Purchase Plan

In connection with the Company’s initial public offering, the Company adopted the Employee Stock Purchase Plan. The Employee Stock Purchase Plan permits employees to purchase shares of common stock during six-month offering periods at a purchase price equal to the lesser of (1) 85% of the fair market value of a share of common stock on the first business day of such offering period and (2) 85% of the fair market value of a share of common stock on the last business day of such offering period. The plan is considered compensatory and, as such, the purchase discount from market price purchased by employees will be recorded as compensation expense. As of March 31, 2020, the maximum number of shares of common stock that can be issued under the employee stock purchase plan was 1,750,000 shares. No offering period started during the three months ended March 31, 2020 and thus there was no activity associated with the plan for the three months ended March 31, 2020.

Stock-based Compensation

Total stock-based compensation expense, excluding compensation expense related to stock sales by current and former employees, by function was as follows (in thousands):

	Three Months Ended March 31,
	2020		2019
Marketing	$	188	$	68
Operations and technology		1,478		490
Selling, general and administrative		1,744		551
Total	$	3,410	$	1,109

The amounts presented in the above table exclude compensation expense related to the stock sales by current and former employees. In March 2019, executives of the Company sold an aggregate of 382,477 shares of the Company’s common stock at a price of $12.72 per share for an aggregate amount of $4.9 million to certain of the Company’s existing investors. The Company determined that the purchase price was in excess of the fair value of such shares. As a result, during the three months ended March 31, 2019, the Company recorded the excess of the purchase price above fair value of $0.8 million as compensation expense within selling, general and administrative in the statement of operations and a corresponding credit to additional paid-in capital.

Leases

3 Months Ended

Mar. 31, 2020

Leases [Abstract]

Leases

Note 9. Leases

The Company leases its corporate offices, retail spaces and merchandising and fulfillment facilities under various noncancelable operating leases with terms ranging from one year to fourteen years.

The Company adopted ASU 2016-02 on January 1, 2020. At adoption, the Company measured the lease liability at the present value of the future lease payments as of January 1, 2020, using the Company’s incremental borrowing rate for each lease. The Company derived the incremental borrowing rate based on its own synthetic credit ratings, corresponding yield curves, and the terms of each lease, from the financial credit market information available at the adoption date. The corresponding right-of-use asset is valued at the amount of the lease liability adjusted for the remaining balance of unamortized lease incentives, prepaid rent and deferred rent as of the adoption date.

The Company recorded operating lease costs of $6.0 million and immaterial variable lease payments for the three months ended March 31, 2020. Rent expense under ASC 840 was $4.1 million for the three months ended March 31, 2019.

Maturities of operating lease liabilities by fiscal year for the Company’s operating leases are as follows (in thousands):

Fiscal Year	Amount
Remainder of 2020	$	16,603
2021		24,123
2022		21,464
2023		20,087
2024		19,678
Thereafter		71,506
Total future minimum payments	$	173,461
Less: Imputed interest		(39,078	)
Present value of operating lease liabilities	$	134,383

As of December 31, 2019, the Company’s future minimum lease payments under the noncancelable operating leases were as follows (in thousands):

Year ending December 31,	Amount
2020	$	20,530
2021		22,059
2022		19,610
2023		18,307
2024		17,957
Thereafter		67,208
Total future minimum payments		165,671

Supplemental cash flow information related to the Company’s operating leases are as follows (in thousands):

Three Months Ended

March 31, 2020

Operating cash flows used for operating leases

4,597

Operating lease assets obtained in exchange for operating lease liabilities

18,122

The weighted average remaining lease term and discount rate for the Company’s operating leases are as follows:

	March 31, 2020
Weighted average remaining lease term	7.9 years
Weighted average discount rate		6.8	%

The Company has leases for certain vehicles that are classified as finance leases. The finance lease right-of-use asset and finance lease liabilities for these vehicle leases are immaterial as of March 31, 2020.

Commitments and Contingencies

3 Months Ended

Mar. 31, 2020

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 10. Commitments and Contingencies

Noncancelable Purchase Commitments

The Company has commitments for cloud services and other services in the ordinary course of business with varying expiration terms through 2022. As of March 31, 2020, there were no material changes to the Company’s noncancelable purchase commitments disclosed in the financial statements in the Annual Report on Form 10-K.

Other Commitments

In January 2018, the Company and the University of Arizona Foundation entered into an endowment agreement (the “Endowment Agreement”) to establish a fund (the “Fund”) to create and grow a gemology degree program in the Department of Geosciences at the University of Arizona (the “University”). The Company agreed to donate a total of $2.0 million, payable in four annual installments of $0.5 million starting in January 2018.

There are no conditions that the University must meet to receive the funds nor any penalties to the University for nonperformance. The Endowment Agreement directs the use of the funds but contains no binding restrictions on the use of the funds. On the execution of the Endowment Agreement, the Company recognized $1.7 million expense for the estimated fair value of the grant, using a discount rate of 10%, to selling, general and administrative expenses in the statements of operations. The Company recognized a corresponding liability for the remaining installment payments and will recognize accretion of the liability as interest expense over the remaining term of the Endowment Agreement.

Interest expense related to the accretion of the grant liability was not material in the three months ended March 31, 2020 and 2019. As of March 31, 2020, the outstanding liability was $0.5 million, which is included in other accrued and current liabilities. As of December 31, 2019, the outstanding liability was $0.9 million, of which $0.5 million is included in other accrued and current liabilities on the balance sheets and $0.4 million is included in other noncurrent liabilities on the balance sheets.

Contingencies

From time to time, the Company is subject to, and it is presently involved in, litigation and other legal proceedings and from time to time, the Company receives inquiries from government agencies. Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. The Company records a loss contingency when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company discloses material contingencies when a loss is not probable but reasonably possible.

On November 14, 2018, Chanel, Inc. (“Chanel”) filed a lawsuit against the Company in the U.S. District Court for the Southern District of New York bringing various trademark and advertising-related claims under the Lanham Act and New York state law analogues. Chanel alleges, among other things, that the Company has misrepresented certain counterfeit Chanel products as authentic Chanel products, that the Company’s resale of Chanel products confuses consumers into believing that Chanel is affiliated with the Company and involved in authenticating consignors’ goods and that only Chanel is capable of authenticating second-hand Chanel goods. The Court issued an Opinion & Order on March 30, 2020 denying in part and granting in part the Company’s motion to dismiss. The Company is due to file its Answer on May 29, 2020. This litigation is in its early stages and the final outcome, including the Company’s liability, if any, with respect to Chanel’s claims, is uncertain. Chanel could in the future assert additional trademark and advertising or other claims against the Company in this or other proceedings. An unfavorable outcome in this or similar litigation could adversely affect the Company’s business and could lead to other similar lawsuits. The Company is not able to predict or reasonably estimate the ultimate outcome or possible losses relating to this claim.

On September 10, 2019, a purported shareholder class action complaint was filed against the Company, its officers and directors and the underwriters of its IPO in the Superior Court of the State of California in the County of San Mateo. Three additional purported class actions, also alleging claims arising from the IPO were subsequently filed in Marin County and San Francisco County Superior Courts. The San Mateo case was voluntarily dismissed, refiled in Marin County Superior Court and consolidated with the cases there. On January 10, 2020, the Marin County plaintiffs filed a consolidated amended complaint. Defendants’ filed a demurrer and motion to strike on March 13, 2020. The plaintiffs in the San Francisco Superior Court case have filed a request for dismissal. Separately an additional purported class action was filed in the United States District Court for the Northern District of California on November 25, 2019. On February 12, 2020, a lead plaintiff was appointed in the federal action. An Amended Consolidated Complaint was filed on March 31, 2020 and defendants are due to file a motion to dismiss on May 15, 2020. The state and federal complaints each allege claims under the Securities Act of 1933 on behalf of a purported class of shareholders who acquired the Company’s stock pursuant to or traceable to the registration statement for the Company’s IPO. The federal complaint also alleges claims under the Securities Exchange Act of 1934 on behalf of a purported class of shareholders who purchased the Company’s stock from June 27, 2019 through November 20, 2019. The complaints allege, among other things, that the defendants violated federal securities laws by issuing false or misleading statements in the registration statement regarding certain of the Company’s key financial and operating metrics, and related to the Company’s authentication processes. The complaints seek, among other things, damages and interest, rescission, and attorneys’ fees and costs. While the Company intends to vigorously defend against this litigation, the cases are at a very early stage and there can be no assurance that the Company will be successful in its defense. For this same reason, the Company cannot currently estimate the loss or the range of possible losses it may experience in connection with this litigation.

Indemnifications

In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to vendors, directors, officers and other parties with respect to certain matters including, but not limited to, losses arising out of the breach of such agreements, intellectual property infringement claims made by third parties and other liabilities relating to or arising from the Company's various services, or its acts or omissions. The Company has not incurred any material costs as a result of such indemnifications and have not accrued any liabilities related to such obligations in its financial statements.

Income Taxes

3 Months Ended

Mar. 31, 2020

Income Tax Disclosure [Abstract]

Income Taxes

Note 11. Income Taxes

The quarterly income tax provision reflects an estimate of the corresponding quarter’s state taxes in the United States.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (CARES) Act (the ‘Act’) was signed into law. The Act provides various forms of income tax relief to companies including additional carryback opportunities for net operating losses (NOLs), and the potential offset of 100% of taxable income with NOLs (as opposed to only 80% before the Act’s enactment). The Act also temporarily increases the interest deductibility threshold from 30% to 50% of adjusted taxable income. Further, some companies can immediately expense qualified improvement property, instead of depreciating those costs over 39 years, for income tax purposes.

Given the Company’s tax attributes, specifically large net operating loss carryforwards, the provisions do not create immediate material tax relief. However, the Company continues to monitor the various tax provisions.

Net Loss Per Share

3 Months Ended

Mar. 31, 2020

Earnings Per Share [Abstract]

Net Loss Per Share

Note 12. Net Loss Per Share

A reconciliation of the numerator and denominator used in the calculation of the basic and diluted net loss per share attributable to common stockholders is as follows (in thousands, except share and per share data):

	Three Months Ended March 31,
	2020			2019
Numerator
Net loss attributable to common stockholders	$	(38,292	)	$	(26,577	)
Denominator
Weighted-average common shares outstanding used to calculate net loss per share attributable to common stockholders, basic and diluted		86,588,796			8,705,664
Net loss per share attributable to common stockholders, basic and diluted	$	(0.44	)	$	(3.05	)

The following securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis):

	March 31,
	2020		2019
Convertible preferred stock		—		38,778,180
Redeemable convertible preferred stock		—		19,585,426
Options to purchase common stock		7,988,747		9,204,328
Restricted stock units		1,752,275		—
Warrants to purchase convertible preferred stock		—		103,563
Warrant to purchase common stock		—		5,742
Total		9,741,022		67,677,239

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Use of Estimates

Net Loss per Share Attributable to Common Stockholders

Revenue Recognition

The Company generates revenue from the sale of pre-owned luxury goods through its online marketplace and retail locations.

Consignment and Service Revenue

Direct Revenue

Incentives

Contract Liabilities

Cost of Revenue

Stock-based Compensation

Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash that sum to the total of the same amounts shown in the statements of cash flows (in thousands):

	March 31, 2020		March 31, 2019
Cash and cash equivalents	$	134,662	$	88,790
Restricted cash		—		11,421
Total cash, cash equivalents and restricted cash	$	134,662	$	100,211

Short-term Investments

Inventory, Net

Our provisions to write down obsolete and excess inventory to net realizable value have not been material for the three months ended March 31, 2020 and 2019.

Software Development Costs

Accretion of Redeemable Convertible Preferred Stock

Convertible Preferred Stock Warrant Liability

Leases

Prior to the adoption of ASC 842

Subsequent to the adoption of ASC 842

The Company has finance leases for several vehicles, and the amounts of finance lease right-of-use assets and finance lease liabilities have been immaterial to date.

Concentrations of Credit Risks

Recently Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash that sum to the total of the same amounts shown in the statements of cash flows (in thousands):

	March 31, 2020		March 31, 2019
Cash and cash equivalents	$	134,662	$	88,790
Restricted cash		—		11,421
Total cash, cash equivalents and restricted cash	$	134,662	$	100,211

Cash, Cash Equivalents and Short-term Investments (Tables)

3 Months Ended

Mar. 31, 2020

Cash And Cash Equivalents [Abstract]

Summary of Estimated Value of Cash, Cash Equivalents and Short-term Investments

The following tables summarize the estimated value of the Company’s cash, cash equivalents and short-term investments (in thousands):

	March 31, 2020
	Amortized Cost		Unrealized Gain		Unrealized Loss			Fair Value
Cash and cash equivalents:
Cash	$	50,257	$	—	$	—		$	50,257
U.S. Treasury securities		39,978		20		—			39,998
Money market fund		39,412		—		—			39,412
Corporate bonds		—		—		—			—
Agency bonds		—		—		—			—
Commercial paper		4,994		1		—			4,995
Total cash and cash equivalents	$	134,641	$	21	$	—		$	134,662
Short-term investments:
U.S. Treasury securities	$	100,928	$	511	$	—		$	101,439
Corporate bonds		51,569		—		(225	)		51,344
Agency bonds		10,000		13		—			10,013
Commercial paper		5,794		2		—			5,796
Total short-term investments	$	168,291	$	526	$	(225	)	$	168,592

	December 31, 2019
	Amortized Cost		Unrealized Gain		Unrealized Loss			Fair Value
Cash and cash equivalents:
Cash	$	111,319	$	—	$	—		$	111,319
U.S. Treasury securities		29,981		—		—			29,981
Money market fund		5,399		—		—			5,399
Corporate bonds		3,749		—		—			3,749
Agency bonds		2,000		—		—			2,000
Commercial paper		1,998		—		—			1,998
Total cash and cash equivalents	$	154,446	$	—	$	—		$	154,446
Short-term investments:
U.S. Treasury securities	$	151,857	$	13	$	—		$	151,870
Corporate bonds		38,149		—		(5	)		38,144
Agency bonds		11,028		—		(2	)		11,026
Commercial paper		7,770		1		—			7,771
Total short-term investments	$	208,804	$	14	$	(7	)	$	208,811

Fair Value Measurement (Tables)

3 Months Ended

Mar. 31, 2020

Fair Value Disclosures [Abstract]

Schedule of Financial Instruments Measured at Fair Value

The following tables provide the financial instruments measured at fair value (in thousands):

	March 31, 2020
	Level 1		Level 2		Level 3		Total
Assets
Cash equivalents:
U.S. Treasury securities	$	39,998	$	—	$	—	$	39,998
Money market fund		39,412		—		—		39,412
Commercial paper		—		4,995		—		4,995
Total cash equivalents	$	79,410	$	4,995	$	—	$	84,405
Short-term investments:
U.S. Treasury securities	$	101,439	$	—	$	—	$	101,439
Corporate bonds		—		51,344		—		51,344
Agency bonds		—		10,013		—		10,013
Commercial paper		—		5,796		—		5,796
Total short-term investments	$	101,439	$	67,153	$	—	$	168,592

	December 31, 2019
	Level 1		Level 2		Level 3		Total
Assets
Cash equivalents:
U.S. Treasury securities	$	29,981	$	—	$	—	$	29,981
Money market fund		5,399		—		—		5,399
Corporate bonds		—		3,749		—		3,749
Agency bonds		—		2,000		—		2,000
Commercial paper		—		1,998		—		1,998
Total cash equivalents	$	35,380	$	7,747	$	—	$	43,127
Short-term investments:
U.S. Treasury securities	$	151,870	$	—	$	—	$	151,870
Corporate bonds		—		38,144		—		38,144
Agency bonds		—		11,026		—		11,026
Commercial paper		—		7,771		—		7,771
Total short-term investments	$	151,870	$	56,941	$	—	$	208,811

Balance Sheet Components (Tables)

3 Months Ended

Mar. 31, 2020

Balance Sheet Related Disclosures [Abstract]

Schedule of Property and Equipment, Net

Property and equipment, net consists of the following (in thousands):

	March 31, 2020			December 31, 2019
Proprietary software	$	25,554		$	23,318
Furniture and equipment		22,848			21,083
Automobiles		491			718
Leasehold improvements		47,207			43,505
		96,100			88,624
Less: accumulated depreciation and amortization		(36,463	)		(32,793	)
Property and equipment, net	$	59,637		$	55,831

Schedule of Other Accrued and Current Liabilities

Other accrued and current liabilities consist of the following (in thousands):

	March 31, 2020		December 31, 2019
Returns reserve	$	10,662	$	17,005
Accrued compensation		8,745		11,626
Site credit liability		5,784		5,080
Accrued sales tax and other taxes		3,984		6,132
Deferred revenue		3,690		4,767
Accrued marketing and outside services		8,728		6,830
Other		2,348		3,127
Other accrued and current liabilities	$	43,941	$	54,567

Convertible Preferred Stock and Redeemable Convertible Preferred Stock (Tables)

3 Months Ended

Mar. 31, 2020

Temporary Equity Disclosure [Abstract]

Summary of Convertible Preferred Stock and Redeemable Convertible Preferred Stock

At March 31, 2019, convertible preferred stock and redeemable convertible preferred stock consisted of the following (in thousands, except share amounts):

	March 31, 2019
	Shares Authorized		Shares Issued and Outstanding		Net Carrying Value		Aggregate Liquidation Preference
Series A		18,960,000		18,941,619	$	9,161	$	9,217
Series B		13,784,443		13,652,791		13,774		14,000
Series C		9,335,659		9,328,791		20,289		20,374
Series D		14,367,652		14,324,642		39,886		40,000
Series E		13,612,543		13,586,946		39,880		40,000
Series F		12,956,724		12,956,724		56,154		58,397
Series G		21,986,733		21,986,733		118,325		123,881
Series H		10,182,113		10,182,111		69,937		70,138
Total		115,185,867		114,960,357	$	367,406	$	376,007

Share-based Compensation Plans (Tables)

3 Months Ended

Mar. 31, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Total Stock-based Compensation Expense, Excluding Compensation Expense Related to Stock Sales, by Function

Total stock-based compensation expense, excluding compensation expense related to stock sales by current and former employees, by function was as follows (in thousands):

	Three Months Ended March 31,
	2020		2019
Marketing	$	188	$	68
Operations and technology		1,478		490
Selling, general and administrative		1,744		551
Total	$	3,410	$	1,109

Leases (Tables)

3 Months Ended

Mar. 31, 2020

Leases [Abstract]

Schedule of Maturities of Operating Lease Liabilities

Maturities of operating lease liabilities by fiscal year for the Company’s operating leases are as follows (in thousands):

Fiscal Year	Amount
Remainder of 2020	$	16,603
2021		24,123
2022		21,464
2023		20,087
2024		19,678
Thereafter		71,506
Total future minimum payments	$	173,461
Less: Imputed interest		(39,078	)
Present value of operating lease liabilities	$	134,383

Schedule of Future Minimum Lease Payments Under Noncancelable Operating Leases

As of December 31, 2019, the Company’s future minimum lease payments under the noncancelable operating leases were as follows (in thousands):

Year ending December 31,	Amount
2020	$	20,530
2021		22,059
2022		19,610
2023		18,307
2024		17,957
Thereafter		67,208
Total future minimum payments		165,671

Schedule of Supplemental Cash Flow Information Related to Operating Leases

Supplemental cash flow information related to the Company’s operating leases are as follows (in thousands):

Three Months Ended

March 31, 2020

Operating cash flows used for operating leases

4,597

Operating lease assets obtained in exchange for operating lease liabilities

18,122

Schedule of Weighted Average Remaining Lease Term and Discount Rate for Operating Leases

The weighted average remaining lease term and discount rate for the Company’s operating leases are as follows:

	March 31, 2020
Weighted average remaining lease term	7.9 years
Weighted average discount rate		6.8	%

Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2020

Earnings Per Share [Abstract]

Schedule of Reconciliation of Numerator and Denominator Used in Calculation of Basic and Diluted Net Loss Per Share

	Three Months Ended March 31,
	2020			2019
Numerator
Net loss attributable to common stockholders	$	(38,292	)	$	(26,577	)
Denominator
Weighted-average common shares outstanding used to calculate net loss per share attributable to common stockholders, basic and diluted		86,588,796			8,705,664
Net loss per share attributable to common stockholders, basic and diluted	$	(0.44	)	$	(3.05	)

Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss Per Share

	March 31,
	2020		2019
Convertible preferred stock		—		38,778,180
Redeemable convertible preferred stock		—		19,585,426
Options to purchase common stock		7,988,747		9,204,328
Restricted stock units		1,752,275		—
Warrants to purchase convertible preferred stock		—		103,563
Warrant to purchase common stock		—		5,742
Total		9,741,022		67,677,239

Description of Business and Basis of Presentation - Additional Information (Details) $ / shares in Units, $ in Thousands		3 Months Ended
	Jul. 02, 2019 USD ($) $ / shares shares	Mar. 31, 2020 shares	Mar. 31, 2019 USD ($) shares	Dec. 31, 2019 shares
Class Of Stock [Line Items]
Issuance costs \| $			$ 222
Common stock, shares authorized		500,000,000		500,000,000
Redeemable convertible preferred stock outstanding			114,960,357
Initial Public Offering
Class Of Stock [Line Items]
Number of common stock issued	15,000,000
Common stock issued price per share \| $ / shares	$ 20.00
Net proceeds from issuance of initial public offering \| $	$ 315,500
Underwriting discounts and commissions \| $	24,100
Issuance costs \| $	$ 5,300
Common stock, shares authorized	500,000,000
Undesignated preferred stock, shares authorized for issuance	50,000,000
Redeemable convertible preferred stock outstanding	114,960,357
Convertible preferred stock converted into common stock	58,363,606
Description of reverse stock split		On June 13, 2019 the Company effected a reverse split of shares of the Company’s common stock on a 1-for-2 basis
Reverse stock split ratio		0.5
Initial Public Offering \| Common Stock Warrants
Class Of Stock [Line Items]
Conversion of preferred stock warrants into common stock warrants	103,563
Underwriters' Option to Purchase Additional Shares
Class Of Stock [Line Items]
Number of common stock issued	2,250,000
Common stock issued price per share \| $ / shares	$ 20.00

Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2020 USD ($) Customer	Mar. 31, 2019 Customer	Dec. 31, 2019 USD ($) Customer	Jan. 01, 2020 USD ($)
Summary Of Significant Accounting Policies [Line Items]
Contractual liabilities	$ 3,690		$ 4,767
Right-of-use asset	124,346			$ 110,300
Current operating lease liabilities	14,209			12,800
Operating lease liabilities, net of current portion	$ 120,174			$ 106,200
Accounts Receivable
Summary Of Significant Accounting Policies [Line Items]
Number of major customers \| Customer	0		0
Total Revenue
Summary Of Significant Accounting Policies [Line Items]
Number of major customers \| Customer		0
Deferred Revenue
Summary Of Significant Accounting Policies [Line Items]
Contractual liabilities	$ 2,600		$ 3,500

Summary of Significant Accounting Policies - Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Accounting Policies [Abstract]
Cash and cash equivalents	$ 134,662	$ 154,446	$ 88,790
Restricted cash			11,421
Total cash, cash equivalents and restricted cash	$ 134,662	$ 154,446	$ 100,211	$ 45,627

Cash, Cash Equivalents and Short-term Investments - Summary of Estimated Value of Cash, Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Cash And Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	$ 134,641	$ 154,446
Cash and cash equivalents, unrealized gain	21
Cash and cash equivalents, fair value	134,662	154,446
Short-term investments, amortized cost	168,291	208,804
Short-term investments, unrealized gain	526	14
Short-term investments, unrealized loss	(225)	(7)
Short-term investments, fair value	168,592	208,811
Cash
Cash And Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	50,257	111,319
Cash and cash equivalents, fair value	50,257	111,319
Money Market Fund
Cash And Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	39,412	5,399
Cash and cash equivalents, fair value	39,412	5,399
Corporate Bonds
Cash And Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost		3,749
Cash and cash equivalents, fair value		3,749
Short-term investments, amortized cost	51,569	38,149
Short-term investments, unrealized loss	(225)	(5)
Short-term investments, fair value	51,344	38,144
Agency Bonds
Cash And Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost		2,000
Cash and cash equivalents, fair value		2,000
Short-term investments, amortized cost	10,000	11,028
Short-term investments, unrealized gain	13
Short-term investments, unrealized loss		(2)
Short-term investments, fair value	10,013	11,026
Commercial Paper
Cash And Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	4,994	1,998
Cash and cash equivalents, unrealized gain	1
Cash and cash equivalents, fair value	4,995	1,998
Short-term investments, amortized cost	5,794	7,770
Short-term investments, unrealized gain	2	1
Short-term investments, fair value	5,796	7,771
U.S. Treasury Securities
Cash And Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	39,978	29,981
Cash and cash equivalents, unrealized gain	20
Cash and cash equivalents, fair value	39,998	29,981
Short-term investments, amortized cost	100,928	151,857
Short-term investments, unrealized gain	511	13
Short-term investments, fair value	$ 101,439	$ 151,870

Cash, Cash Equivalents and Short-term Investments - Additional Information (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Maximum
Cash And Cash Equivalents [Line Items]
Short term investments contractual maturity term	1 year	1 year

Fair Value Measurement - Additional Information (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Asset transfers Level 1 to Level 2	$ 0	$ 0
Asset transfers Level 2 to Level 1	0	0
Asset transfers into Level 3	0	0
Asset transfers out of Level 3	0	0
Liabilities transfers Level 1 to Level 2	0	0
Liabilities transfers Level 2 to Level 1	0	0
Liability transfers into Level 3	0	0
Liability transfers out of Level 3	$ 0	$ 0

Fair Value Measurement - Schedule of Financial Instruments Measured at Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Assets
Cash equivalents	$ 134,662	$ 154,446
Short-term investments	168,592	208,811
Recurring
Assets
Cash equivalents	84,405	43,127
Short-term investments	168,592	208,811
Recurring \| U.S. Treasury Securities
Assets
Cash equivalents	39,998	29,981
Short-term investments	101,439	151,870
Recurring \| Money Market Fund
Assets
Cash equivalents	39,412	5,399
Recurring \| Corporate Bonds
Assets
Cash equivalents		3,749
Short-term investments	51,344	38,144
Recurring \| Agency Bonds
Assets
Cash equivalents		2,000
Short-term investments	10,013	11,026
Recurring \| Commercial Paper
Assets
Cash equivalents	4,995	1,998
Short-term investments	5,796	7,771
Recurring \| Level 1
Assets
Cash equivalents	79,410	35,380
Short-term investments	101,439	151,870
Recurring \| Level 1 \| U.S. Treasury Securities
Assets
Cash equivalents	39,998	29,981
Short-term investments	101,439	151,870
Recurring \| Level 1 \| Money Market Fund
Assets
Cash equivalents	39,412	5,399
Recurring \| Level 2
Assets
Cash equivalents	4,995	7,747
Short-term investments	67,153	56,941
Recurring \| Level 2 \| Corporate Bonds
Assets
Cash equivalents		3,749
Short-term investments	51,344	38,144
Recurring \| Level 2 \| Agency Bonds
Assets
Cash equivalents		2,000
Short-term investments	10,013	11,026
Recurring \| Level 2 \| Commercial Paper
Assets
Cash equivalents	4,995	1,998
Short-term investments	$ 5,796	$ 7,771

Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 96,100	$ 88,624
Less: accumulated depreciation and amortization	(36,463)	(32,793)
Property and equipment, net	59,637	55,831
Proprietary Software
Property Plant And Equipment [Line Items]
Property and equipment, gross	25,554	23,318
Furniture And Equipment
Property Plant And Equipment [Line Items]
Property and equipment, gross	22,848	21,083
Automobiles
Property Plant And Equipment [Line Items]
Property and equipment, gross	491	718
Leasehold Improvements
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 47,207	$ 43,505

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Property Plant And Equipment [Abstract]
Depreciation and amortization expense on property and equipment	$ 4.1	$ 2.8

Balance Sheet Components - Schedule of Other Accrued and Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Payables And Accruals [Abstract]
Returns reserve	$ 10,662	$ 17,005
Accrued compensation	8,745	11,626
Site credit liability	5,784	5,080
Accrued sales tax and other taxes	3,984	6,132
Deferred revenue	3,690	4,767
Accrued marketing and outside services	8,728	6,830
Other	2,348	3,127
Other accrued and current liabilities	$ 43,941	$ 54,567

Debt and Convertible Preferred Stock Warrants - Additional Information (Details) - USD ($)		1 Months Ended		3 Months Ended		6 Months Ended	12 Months Ended
	Jul. 26, 2019	Jul. 31, 2019	Jun. 30, 2018	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2018	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2013
Debt Disclosure [Line Items]
Interest expense related to term loans				$ 0	$ 100,000
Warrants outstanding				0
Letter of Credit
Debt Disclosure [Line Items]
Deb maturity date							Aug. 01, 2019
Line of credit							$ 1,500,000
IPO
Debt Disclosure [Line Items]
Debt, success fee		$ 300,000
Series G Convertible Preferred Stock
Debt Disclosure [Line Items]
Debt, success fee			$ 100,000
Series B Convertible Preferred Stock
Debt Disclosure [Line Items]
Outstanding preferred stock warrants exercised (in shares)				131,652
Exercise price of warrants (in dollars per share)				$ 1.03
Series C Convertible Preferred Stock
Debt Disclosure [Line Items]
Outstanding preferred stock warrants exercised (in shares)				6,868
Exercise price of warrants (in dollars per share)				$ 2.18
Series D Convertible Preferred Stock
Debt Disclosure [Line Items]
Outstanding preferred stock warrants exercised (in shares)				43,010
Exercise price of warrants (in dollars per share)				$ 2.79
Series E Convertible Preferred Stock
Debt Disclosure [Line Items]
Outstanding preferred stock warrants exercised (in shares)				25,597
Exercise price of warrants (in dollars per share)				$ 2.93
Convertible Preferred Stock
Debt Disclosure [Line Items]
Warrant term				10 years
Term Loan Facility
Debt Disclosure [Line Items]
Maximum borrowing capacity									$ 5,000,000
Increase in borrowing capacity				$ 11,600,000
Debt instrument required covenants percentage on forecasted gross revenue				80.00%
Debt, combined success fee							$ 300,000
Debt, additional success fee						$ 100,000
Net cash proceeds from subordinated debt securities						$ 50,000,000
Term Loans
Debt Disclosure [Line Items]
Long-term debt, gross								$ 15,000,000
Repayments on loans	$ 6,500,000
Term Loan I
Debt Disclosure [Line Items]
Long-term debt, gross								$ 7,500,000
Deb maturity date							Jan. 31, 2021	Jan. 31, 2019
Number of equal monthly installments				30 equal monthly installments
Variable annual interest rate							0.35%	0.10%
Term Loan II
Debt Disclosure [Line Items]
Long-term debt, gross								$ 7,500,000
Deb maturity date								Jan. 01, 2020

Convertible Preferred Stock and Redeemable Convertible Preferred Stock - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended	3 Months Ended
	Jul. 02, 2019	Mar. 31, 2019	Mar. 31, 2019
Temporary Equity [Line Items]
Aggregate gross proceeds			$ 26,279
Initial Public Offering
Temporary Equity [Line Items]
Convertible preferred stock converted into common stock	58,363,606
Series H
Temporary Equity [Line Items]
Redeemable convertible preferred stock issued		6,350,345
Convertible preferred stock issued		3,831,766
Preferred stock par value		$ 6.8748	$ 6.8748
Aggregate gross proceeds		$ 70,000

Convertible Preferred Stock and Redeemable Convertible Preferred Stock - Summary of Convertible Preferred Stock and Redeemable Convertible Preferred Stock (Details) $ in Thousands	Mar. 31, 2019 USD ($) shares
Temporary Equity [Line Items]
Shares Authorized	115,185,867
Shares Issued	114,960,357
Shares Outstanding	114,960,357
Net Carrying Value \| $	$ 367,406
Aggregate Liquidation Preference \| $	$ 376,007
Series A
Temporary Equity [Line Items]
Shares Authorized	18,960,000
Shares Issued	18,941,619
Shares Outstanding	18,941,619
Net Carrying Value \| $	$ 9,161
Aggregate Liquidation Preference \| $	$ 9,217
Series B
Temporary Equity [Line Items]
Shares Authorized	13,784,443
Shares Issued	13,652,791
Shares Outstanding	13,652,791
Net Carrying Value \| $	$ 13,774
Aggregate Liquidation Preference \| $	$ 14,000
Series C
Temporary Equity [Line Items]
Shares Authorized	9,335,659
Shares Issued	9,328,791
Shares Outstanding	9,328,791
Net Carrying Value \| $	$ 20,289
Aggregate Liquidation Preference \| $	$ 20,374
Series D
Temporary Equity [Line Items]
Shares Authorized	14,367,652
Shares Issued	14,324,642
Shares Outstanding	14,324,642
Net Carrying Value \| $	$ 39,886
Aggregate Liquidation Preference \| $	$ 40,000
Series E
Temporary Equity [Line Items]
Shares Authorized	13,612,543
Shares Issued	13,586,946
Shares Outstanding	13,586,946
Net Carrying Value \| $	$ 39,880
Aggregate Liquidation Preference \| $	$ 40,000
Series F
Temporary Equity [Line Items]
Shares Authorized	12,956,724
Shares Issued	12,956,724
Shares Outstanding	12,956,724
Net Carrying Value \| $	$ 56,154
Aggregate Liquidation Preference \| $	$ 58,397
Series G
Temporary Equity [Line Items]
Shares Authorized	21,986,733
Shares Issued	21,986,733
Shares Outstanding	21,986,733
Net Carrying Value \| $	$ 118,325
Aggregate Liquidation Preference \| $	$ 123,881
Series H
Temporary Equity [Line Items]
Shares Authorized	10,182,113
Shares Issued	10,182,111
Shares Outstanding	10,182,111
Net Carrying Value \| $	$ 69,937
Aggregate Liquidation Preference \| $	$ 70,138

Share-based Compensation Plans - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended		12 Months Ended
	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2011
Selling, General and Administrative
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Compensation expense			$ 0.8
Common Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares issued in transaction	382,477
Sale of stock, price per share	$ 12.72		$ 12.72
Sale of stock, aggregate amount	$ 4.9
Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares authorized		1,750,000
Employee Stock Purchase Plan \| First Business Day
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options granted as percentage on fair value of stock		85.00%
Employee Stock Purchase Plan \| Last Business Day
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options granted as percentage on fair value of stock		85.00%
2011 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period				4 years
Percentage of maximum incentive stock options granted to stockholders				10.00%
2011 Plan \| Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options exercisable period				10 years
2011 Plan \| Incentive and Non-statutory Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares authorized				12,987,255
2011 Plan \| Incentive and Non-statutory Stock Options \| Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options granted as percentage on fair value of stock				100.00%
2011 Plan \| Incentive Stock Options \| Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options granted as percentage on fair value of stock				110.00%
2019 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares authorized		8,000,000

Share-based Compensation Plans - Schedule of Total Stock-based Compensation Expense, Excluding Compensation Expense Related to Stock Sales, by Function (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total stock-based compensation expense	$ 3,410	$ 1,109
Marketing
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total stock-based compensation expense	188	68
Operations and Technology
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total stock-based compensation expense	1,478	490
Selling, General and Administrative
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total stock-based compensation expense	$ 1,744	$ 551

Leases - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Line Items]
Operating lease costs	$ 6.0
Rent expense from operating leases		$ 4.1
Minimum
Leases [Line Items]
Operating lease term	1 year
Maximum
Leases [Line Items]
Operating lease term	14 years

Leases - Schedule of Maturities of Operating Lease Liabilities (Details) $ in Thousands	Mar. 31, 2020 USD ($)
Leases [Abstract]
Remainder of 2020	$ 16,603
2021	24,123
2022	21,464
2023	20,087
2024	19,678
Thereafter	71,506
Total future minimum payments	173,461
Less: Imputed interest	(39,078)
Present value of operating lease liabilities	$ 134,383

Leases - Schedule of Future Minimum Lease Payments Under Noncancelable Operating Leases (Details) $ in Thousands	Dec. 31, 2019 USD ($)
Leases [Abstract]
2020	$ 20,530
2021	22,059
2022	19,610
2023	18,307
2024	17,957
Thereafter	67,208
Total future minimum payments	$ 165,671

Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020 USD ($)
Leases [Abstract]
Operating cash flows used for operating leases	$ 4,597
Operating lease assets obtained in exchange for operating lease liabilities	$ 18,122

Leases - Schedule of Weighted Average Remaining Lease Term and Discount Rate For Operating Leases (Details)	Mar. 31, 2020
Leases [Abstract]
Weighted average remaining lease term	7 years 10 months 24 days
Weighted average discount rate	6.80%

Commitments and Contingencies - Additional Information (Details) $ in Millions	1 Months Ended
	Jan. 31, 2018 USD ($) Installment	Mar. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
Other Commitments [Line Items]
Outstanding liability		$ 0.5	$ 0.9
Other Accrued and Current Liabilities
Other Commitments [Line Items]
Outstanding liability			0.5
Other Noncurrent Liabilities
Other Commitments [Line Items]
Outstanding liability			$ 0.4
Selling, General and Administrative
Other Commitments [Line Items]
Estimated fair value of grant expense	$ 1.7
Fair value of grant, discount rate	10.00%
Endowment Agreement
Other Commitments [Line Items]
Donation fund	$ 2.0
Annual installment payment of donation fund	$ 0.5
Number of annual installments \| Installment	4

Income Taxes - Additional Information (Details) - Coronavirus Aid, Relief, and Economic Security Act (CARES)	Mar. 27, 2020
Operating Loss Carryforwards [Line Items]
Potential offset percentage of taxable income with NOLs	100.00%
Potential offset of taxable income before act enactment percentage	80.00%
Minimum
Operating Loss Carryforwards [Line Items]
Temporarily increases the interest deductibility threshold percentage of adjusted taxable income	30.00%
Maximum
Operating Loss Carryforwards [Line Items]
Temporarily increases the interest deductibility threshold percentage of adjusted taxable income	50.00%
Depreciating costs over for income tax purposes	39 years

Net Loss Per Share - Schedule of Reconciliation of Numerator and Denominator Used in Calculation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Numerator
Net loss attributable to common stockholders	$ (38,292)	$ (26,577)
Denominator
Weighted-average common shares outstanding used to calculate net loss per share attributable to common stockholders, basic and diluted	86,588,796	8,705,664
Net loss per share attributable to common stockholders, basic and diluted	$ (0.44)	$ (3.05)

Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted net loss per share	9,741,022	67,677,239
Convertible Preferred Stock
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted net loss per share		38,778,180
Redeemable Convertible Preferred Stock
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted net loss per share		19,585,426
Options to Purchase Common Stock
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted net loss per share	7,988,747	9,204,328
Restricted Stock Units
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted net loss per share	1,752,275
Warrants \| Convertible Preferred Stock
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted net loss per share		103,563
Warrants \| Common Stock
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted net loss per share		5,742